116 related articles for article (PubMed ID: 92342)
1. Studies on the activation of canine trypsinogens in vitro.
Borgström A; Ohlsson K
Biochim Biophys Acta; 1979 Dec; 571(2):284-93. PubMed ID: 92342
[TBL] [Abstract][Full Text] [Related]
2. Comparative studies on the mechanism of activation of the two human trypsinogens.
Colomb E; Figarella C
Biochim Biophys Acta; 1979 Dec; 571(2):343-51. PubMed ID: 508771
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies to human pancreatic trypsin 1 inhibit the activation of human trypsinogens 1 and 2.
Guy-Crotte O; Miszczuk-Jamska B; Brayle A; Lafont P; Figarella C
Eur J Biochem; 1992 Feb; 204(1):133-6. PubMed ID: 1371252
[TBL] [Abstract][Full Text] [Related]
4. Molecular forms of immunoreactive pancreatic cationic trypsin in pancreatitis patient sera.
Brodrick JW; Geokas MC; Largman C; Fassett M; Johnson JH
Am J Physiol; 1979 Nov; 237(5):E474-80. PubMed ID: 91323
[TBL] [Abstract][Full Text] [Related]
5. Behaviour of serum immunoreactive trypsin after serum activation by enterokinase in normal and cystic fibrosis patients. Evidence of a trypsin-alpha 1-proteinase inhibitor complex in some cystic fibrosis patients.
Carrère J; Chazalette JP; Figarella C
Biochim Biophys Acta; 1989 Dec; 993(2-3):137-42. PubMed ID: 2480820
[TBL] [Abstract][Full Text] [Related]
6. Alpha 1-antitrypsin and alpha 2-macroglobulin do not inhibit the kinin-releasing activity of kallikreins from human urine and saliva.
Sakamoto W; Nishikaze O
Biochim Biophys Acta; 1980 Dec; 633(3):305-9. PubMed ID: 6163451
[TBL] [Abstract][Full Text] [Related]
7. Cationic proteins of human granulocytes. V. Interaction with plasma protease inhibitors.
Venge P; Olsson I; Odeberg H
Scand J Clin Lab Invest; 1975 Dec; 35(8):737-44. PubMed ID: 54932
[TBL] [Abstract][Full Text] [Related]
8. Characterization of trypsinogens 1 and 2 in two human pancreatic adenocarcinoma cell lines; CFPAC-1 and CAPAN-1.
Miszczuk-Jamska B; Merten M; Guy-Crotte O; Amouric M; Clemente F; Schoumacher RA; Figarella C
FEBS Lett; 1991 Dec; 294(3):175-8. PubMed ID: 1756857
[TBL] [Abstract][Full Text] [Related]
9. The fate of intravenously injected trypsinogens in dogs.
Borgström A
Scand J Gastroenterol; 1981; 16(2):281-7. PubMed ID: 7313540
[TBL] [Abstract][Full Text] [Related]
10. The inhibitory effect of heparin on trypsinogen activation with enterokinase.
Wolosowicz N; Prokopowicz J; Gabryelewicz A
Acta Hepatogastroenterol (Stuttg); 1977 Oct; 24(5):368-71. PubMed ID: 930538
[TBL] [Abstract][Full Text] [Related]
11. Studies on the role of the plasma protease inhibitors on in vitro C3 activation and in acute pancreatitis.
Balldin G; Eddeland A; Ohlsson K
Scand J Gastroenterol; 1981; 16(5):603-9. PubMed ID: 6172839
[TBL] [Abstract][Full Text] [Related]
12. Immunoreactive trypsins in sera from dogs before and after induction of experimental pancreatitis.
Borgström A; Ohlsson K
Hoppe Seylers Z Physiol Chem; 1980 May; 361(5):625-31. PubMed ID: 6159294
[TBL] [Abstract][Full Text] [Related]
13. The two human trypsinogens. Evidence of complex formation with basic pancreatic trypsin inhibitor-proteolytic activity.
Colomb E; Figarella C; Guy O
Biochim Biophys Acta; 1979 Oct; 570(2):397-405. PubMed ID: 40607
[TBL] [Abstract][Full Text] [Related]
14. Immunoreactive forms of cationic trypsin in plasma and ascitic fluid of dogs in experimental pancreatitis.
Geokas MC; Largman C; Durie PR; Brodrick JW; Ray SB; O'Rourke M; Vollmer J
Am J Pathol; 1981 Oct; 105(1):31-9. PubMed ID: 6170231
[TBL] [Abstract][Full Text] [Related]
15. Acute pancreatitis in Soweto, South Africa: relationship between trypsinogen load, trypsinogen activation, and fibrinolysis.
Segal I; Chaloner C; Douglas J; John KD; Zaidi A; Cotter L; Appelros S; Borgström A; Braganza JM
Am J Gastroenterol; 2002 Apr; 97(4):883-92. PubMed ID: 12003423
[TBL] [Abstract][Full Text] [Related]
16. The role of alpha1-antitrypsin and alpha-macroglobulins in the uptake of proteinase by rabbit alveolar macrophages.
Dolovich J; Debanne MT; Bell R
Am Rev Respir Dis; 1975 Oct; 112(4):521-5. PubMed ID: 54012
[TBL] [Abstract][Full Text] [Related]
17. Human anionic trypsinogen: properties of autocatalytic activation and degradation and implications in pancreatic diseases.
Kukor Z; Tóth M; Sahin-Tóth M
Eur J Biochem; 2003 May; 270(9):2047-58. PubMed ID: 12709065
[TBL] [Abstract][Full Text] [Related]
18. On the potential role of trypsin and trypsin inhibitors in acute pancreatitis.
Lasson A; Ohlsson K
Adv Exp Med Biol; 1984; 167():477-87. PubMed ID: 6201050
[TBL] [Abstract][Full Text] [Related]
19. Determination of human pancreatic cationic trypsinogen in serum by radioimmunoassay.
Geokas MC; Largman C; Brodrick JW; Johnson JH
Am J Physiol; 1979 Jan; 236(1):E77-83. PubMed ID: 434151
[TBL] [Abstract][Full Text] [Related]
20. The action of potato inhibitors on activation of zymogen forms of digestive system proteases.
Worowski K; Gabryelewicz A; Roszkowska W; Bajko K
Acta Hepatogastroenterol (Stuttg); 1979 Oct; 26(5):413-6. PubMed ID: 525219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
